Y-mAbs Therapeutics

YMAB57

$14.04arrow_drop_down0.77%-$0.10

YMAB57

$14.04

arrow_drop_down0.77%-$0.10

Trendlines, Support and Resistance

lock

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Technical Indicators

Name	Value	Action	infoPnL (10y)
auto_graphRSI	52.93	Neutral	75.8%
auto_graphMACD	0.01	Neutral	-11.5%
auto_graphCCI	45.88	Neutral	-51.7%
auto_graphADX	15.40	Neutral	-
auto_graphATR	3.86	Buy	-
auto_graphWILLR	-43.68	Neutral	-63.1%
auto_graphROC	98.82	Neutral	7.3%
auto_graphSTOCHRSI	77.96	Neutral	-23.4%

Indicator Ratings

Hold

Buy	1	12.50%
Hold	7	87.50%
Sell	0	0.00%

•Ratings from: October•

•Total: 8

info

Balanced or Uncertain

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Y-mAbs Therapeutics (YMAB) Technical Analysis

Y-mAbs Therapeutics Inc (YMAB) is a biopharmaceutical company that focuses on the development and commercialization of novel antibody-based therapeutics for the treatment of cancer. The company's pipeline includes several antibody candidates targeting various types of cancer, including neuroblastoma, melanoma, and small cell lung cancer. YMAB utilizes advanced technologies and proprietary platforms to discover and develop these innovative therapeutics. As an investor, it is essential to analyze the technical aspects of YMAB's stock to make informed investment decisions.

One important technical indicator to consider is the Relative Strength Index (RSI). The RSI is a momentum oscillator that measures the speed and change of stock price movements. It can indicate whether a stock is overbought or oversold. YMAB's stock RSI is currently at [RSI value], suggesting [analysis].

Keep an eye on Y-mAbs Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What are the technical signals for Y-mAbs Therapeutics (YMAB) stock based on the last 30 days?

The technical analysis for Y-mAbs Therapeutics (YMAB), using 8 key indicators (RSI, MACD, CCI, ADX, ATR, WILLR, ROC, STOCHRSI) over the last 30 days, reveals: 1 technical buy signals, including ATR. 1 technical sell signals, identified by STOCHRSI. 6 technical hold signals, associated with RSI, MACD, CCI, ADX, WILLR, and ROC. This analysis was last updated 2024 Oct 07.